FDA Alert: Recombinant Human Growth Hormone (somatropin): Ongoing Safety Review - Possible Increased Risk of Death
Links shared publicly online about this topic.
- 94total visits
FDA Alert: Recombinant Human Growth Hormone (somatropin): Ongoing Safety Review - Possible Increased Risk of Death
FDA Alert: Recombinant Human Growth Hormone (somatropin): Ongoing Safety Review - Possible Increased Risk of Death
View full resource at drugs.com
Tags: Prader-Willi Syndrome Medication, Turner Syndrome Medication, Hormone, Growth Failure Medication, FDA, Genotropin, Norditropin, Safety
Most Recently Shared on August 6, 2011 at 12:11 am By:
FDA Alert - Ongoing Safety Review: Recombinant Human Growth Hormone (somatropin) - Possible Increased Risk of Death - http://bit.ly/rnFswC
Advertisement
